Shwe Sin Kyaw

Shwe Sin is a postdoctoral researcher at the University of Oxford. She is passionate about infectious disease modelling, economic modelling, and policy engagement. 

She is currently working on the cost of Ivermectin drug to include in the mass malaria intervention costing tool. She is interested in the human papillomavirus, which still poses a significant burden on many countries despite the deployment of vaccination and screening programs.  She plans to develop an economic-epidemiological model to evaluate the return on investment of human papillomavirus interventions, especially for low and middle-income countries. The model's output will be combined with health financing analyses to form bespoke investment cases tailored to specific countries and regions. 

Before joining the team at Oxford, she worked at the Mahidol Oxford Research Unit based in Thailand. During that time, she completed her PhD at Mahidol University, where her thesis focused on estimating the cost of implementing malaria interventions, including mass drug administration. Additionally, she developed a mass malaria intervention costing tool to predict the programmatic costs of malaria interventions to support malaria elimination efforts. She is also a medical doctor and has clinical and public health experience in resource-limited settings, which makes her research even more valuable.